CHEBI:28077 - rifampicin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name rifampicin
ChEBI ID CHEBI:28077
Definition A member of the class of rifamycins that is a a semisynthetic antibiotic derived from Amycolatopsis rifamycinica (previously known as Amycolatopsis mediterranei and Streptomyces mediterranei).
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:45308, CHEBI:8858, CHEBI:26577
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C43H58N4O12
Net Charge 0
Average Mass 822.94020
Monoisotopic Mass 822.40512
InChI InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1
InChIKey JQXXHWHPUNPDRT-WLSIYKJHSA-N
SMILES CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(\C=N\N1CCN(C)CC1)c(O)c4c3C2=O
Metabolite of Species Details
Escherichia coli (NCBI:txid562) See: PubMed
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): EC 2.7.7.6 (RNA polymerase) inhibitor
An EC 2.7.7.* (nucleotidyltransferase) inhibitor that interferes with the action of RNA polymerase (EC 2.7.7.6).
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
DNA synthesis inhibitor
Any substance that inhibits the synthesis of DNA.
leprostatic drug
A substance that suppresses Mycobacterium leprae, ameliorates the clinical manifestations of leprosy, and/or reduces the incidence and severity of leprous reactions.
antitubercular agent
A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.
protein synthesis inhibitor
A compound, usually an anti-bacterial agent or a toxin, which inhibits the synthesis of a protein.
pregnane X receptor agonist
An agonist that selectively binds to and activates a pregnane X receptor.
Application(s): leprostatic drug
A substance that suppresses Mycobacterium leprae, ameliorates the clinical manifestations of leprosy, and/or reduces the incidence and severity of leprous reactions.
antitubercular agent
A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.
antiamoebic agent
An antiparasitic agent which is effective against amoeba, a genus of single-celled amoeboids in the family Amoebidae.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
angiogenesis inhibitor
An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
geroprotector
Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing rifampicin (CHEBI:28077) has role Escherichia coli metabolite (CHEBI:76971)
rifampicin (CHEBI:28077) has role angiogenesis inhibitor (CHEBI:48422)
rifampicin (CHEBI:28077) has role antiamoebic agent (CHEBI:171664)
rifampicin (CHEBI:28077) has role antineoplastic agent (CHEBI:35610)
rifampicin (CHEBI:28077) has role antitubercular agent (CHEBI:33231)
rifampicin (CHEBI:28077) has role DNA synthesis inhibitor (CHEBI:59517)
rifampicin (CHEBI:28077) has role EC 2.7.7.6 (RNA polymerase) inhibitor (CHEBI:37416)
rifampicin (CHEBI:28077) has role geroprotector (CHEBI:176497)
rifampicin (CHEBI:28077) has role leprostatic drug (CHEBI:35816)
rifampicin (CHEBI:28077) has role neuroprotective agent (CHEBI:63726)
rifampicin (CHEBI:28077) has role pregnane X receptor agonist (CHEBI:77318)
rifampicin (CHEBI:28077) has role protein synthesis inhibitor (CHEBI:48001)
rifampicin (CHEBI:28077) is a N-iminopiperazine (CHEBI:46847)
rifampicin (CHEBI:28077) is a N-methylpiperazine (CHEBI:46920)
rifampicin (CHEBI:28077) is a cyclic ketal (CHEBI:59779)
rifampicin (CHEBI:28077) is a hydrazone (CHEBI:38532)
rifampicin (CHEBI:28077) is a rifamycins (CHEBI:26580)
rifampicin (CHEBI:28077) is a semisynthetic derivative (CHEBI:72588)
rifampicin (CHEBI:28077) is tautomer of rifampicin zwitterion (CHEBI:71365)
Incoming 2'-hydroxyrifampicin (CHEBI:111544) has functional parent rifampicin (CHEBI:28077)
21-phosphorifampicin (CHEBI:140276) has functional parent rifampicin (CHEBI:28077)
rifampicin zwitterion (CHEBI:71365) is tautomer of rifampicin (CHEBI:28077)
IUPAC Name
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate
INNs Sources
rifampicin KEGG DRUG
rifampicina DrugBank
rifampicinum DrugBank
Synonyms Sources
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV ChemIDplus
RFP DrugBank
rifamcin ChEBI
Rifampicin KEGG COMPOUND
Rifampin KEGG COMPOUND
Manual Xrefs Databases
C06688 KEGG COMPOUND
D00211 KEGG DRUG
DB01045 DrugBank
HMDB0015179 HMDB
NL6509961 Patent
RFP PDBeChem
Rifampicin Wikipedia
US3342810 Patent
View more database links
Registry Numbers Types Sources
13292-46-1 CAS Registry Number KEGG COMPOUND
13292-46-1 CAS Registry Number ChemIDplus
5723476 Beilstein Registry Number Beilstein
5723476 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
11600355 PubMed citation Europe PMC
14665784 PubMed citation Europe PMC
14670633 PubMed citation Europe PMC
15331348 PubMed citation Europe PMC
15383168 PubMed citation Europe PMC
15705662 PubMed citation Europe PMC
16159084 PubMed citation Europe PMC
16515773 PubMed citation Europe PMC
17828712 PubMed citation Europe PMC
18332862 PubMed citation Europe PMC
19386087 PubMed citation Europe PMC
19458074 PubMed citation Europe PMC
19723399 PubMed citation Europe PMC
24718527 PubMed citation Europe PMC
25720500 PubMed citation Europe PMC
26725427 PubMed citation Europe PMC
26819743 PubMed citation Europe PMC
27082586 PubMed citation Europe PMC
27143080 PubMed citation Europe PMC
27182275 PubMed citation Europe PMC
27242224 PubMed citation Europe PMC
27470132 PubMed citation Europe PMC
27569735 PubMed citation Europe PMC
27617596 PubMed citation Europe PMC
27640793 PubMed citation Europe PMC
27755552 PubMed citation Europe PMC
27795624 PubMed citation Europe PMC
27883163 PubMed citation Europe PMC
27965540 PubMed citation Europe PMC
27993874 PubMed citation Europe PMC
28081169 PubMed citation Europe PMC
28118809 PubMed citation Europe PMC
28181840 PubMed citation Europe PMC
28184157 PubMed citation Europe PMC
28207542 PubMed citation Europe PMC
28262820 PubMed citation Europe PMC
Last Modified
28 October 2021